retatrutide phase 2 nejm 2023 obesity trial results 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Tirzepatide for Heart Failure with

In this study, we have investigated the effects of moderate exercise (1 h/day, 5 days a week for 60 days) on mitochondrial, metabolic, and oxidative stress-related changes in the liver and kidney of type 2 diabetic Goto-Kakizaki (GK) rats

Online patient discussion groups often contain questions about where compounders are obtaining their starting ingredients, and they sometimes share Certificates of Analysis (COAs) to try and reassure fellow patients about the sterility and potency of the products and the starting ingredients

Cancer-associated fibroblast-secreted exosomal miR-454-3p inhibits lipid metabolism and ferroptosis in breast cancer by targeting ACSL4

For moderate overdoses (two to three times the intended dose), symptoms are usually self-limiting